Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7865780 | 1.00 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL133918 | 1.00 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| Sulfuric Acid SCHEMBL28494040 | 0.94 | CA12 (0.33) | KMT2ATDP1MAOAMAOBCA1 | |
| SCHEMBL2342887 | 0.86 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL21359614 | 0.86 | DGAT1 (0.31) | DGAT1 | |
| SCHEMBL2823978 | 0.86 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL2342888 | 0.86 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL21359615 | 0.86 | DGAT1 (0.31) | DGAT1 | |
| SCHEMBL15177020 | 0.84 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL14535778 | 0.84 | APLNR (0.38) | KMT2ATDP1CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1096 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12285501-B2 | Compound targeting norepinephrine transporter | Higuchi, Takahiro (DE) | 2025-04-29 | — | — | US | claimed |
| US-20230272006-A1 | PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-08-31 | — | — | US | claimed |
| US-20230100243-A1 | PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-03-30 | — | — | US | claimed |
| EP-3911372-B1 | COMPOUND TARGETING NOREPINEPHRINE TRANSPORTER | GUANGZHOU MIPHERE MEDICAL TECH CO LTD (CN) | 2022-11-30 | — | — | EP | claimed |
| US-20220096667-A1 | Compound Targeting Norepinephrine Transporter | Guangzhou Miphere Medical Technology Co., Ltd. (CN) | 2022-03-31 | — | — | US | claimed |
| EP-3682906-A1 | COMPOUND TARGETING NOREPINEPHRINE TRANSPORTER | Julius-Maximilians-Universität Würzburg (DE) | 2020-07-22 | — | — | EP | claimed |
| US-9403855-B2 | Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses | ACADEMIA SINICA (TW) | 2016-08-02 | — | — | US | claimed |
| US-20150368192-A1 | A METHOD OF SYNTHESIZING CREATINE DERIVATIVES | UNIV DEGLI STUDI GENOVA (IT) | 2015-12-24 | — | — | US | claimed |
| EP-2935207-A1 | A METHOD OF SYNTHESIZING CREATINE DERIVATIVES | Universita' degli Studi di Genova (IT) | 2015-10-28 | — | — | EP | claimed |
| EP-2568976-B1 | ZANAMIVIR PHOSPHONATE CONGENERS WITH ANTI-INFLUENZA ACTIVITY AND DETERMINING OSELTAMIVIR SUSCEPTIBILITY OF INFLUENZA VIRUSES | ACADEMIA SINICA (TW) | 2015-09-30 | — | — | EP | claimed |
| US-7928063-B2 | Analogs of human growth hormone-releasing hormone, their preparation and use | INSTYTUT FARMACEUTYCZNY (PL) | 2011-04-19 | — | — | US | claimed |
| US-20100234588-A1 | SYNTHETIC METHOD FOR CERATAMINE A AND B AND ANALOGS THEREOF | THE OHIO STATE UNIVERSITY (US) | 2010-09-16 | — | — | US | claimed |
| EP-1442059-B1 | ANALOGS OF HUMAN GROWTH HORMONE-RELEASING HORMONE, THEIR PREPARATION AND USE | INST FARMACEUTYCZNY (PL) | 2007-02-14 | — | — | EP | claimed |
| US-20060293328-A1 | Linear dicationic terphenyls and their aza analogues as antiparasitic agents | TIDWELL RICHARD R | 2006-12-28 | — | — | US | claimed |
| EP-1736466-A1 | Linear dicationic terphenyls and their aza analogues as antiparasitic agents | The University of North Carolina at Chapel Hill (US) | 2006-12-27 | — | — | EP | claimed |
| US-20060264608-A1 | Bi-directional synthesis of oligoguanidine transport agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-11-23 | — | — | US | claimed |
| US-6486174-B2 | TREATMENT OF TUMOR GROWTH, METASTASIS, RESTENOSIS, OSTEOPOROSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, RHEUMATOID ARTHRITIS, SICKLE CELL ANEMIA, NERVE SYSTEM DISORDERS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-11-26 | — | — | US | claimed |
| US-20020061885-A1 | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-05-23 | — | — | US | claimed |
| WO-2002012193-A1 | TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID ALKOXYGUANIDINES AS INTEGRIN ANTAGONISTS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2002-02-14 | — | — | WO | claimed |
| US-6344484-B1 | TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-02-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100243-A1 | PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF | GMPS, PAM, SRM | KMT2A 3273/4885NFKB1 2460/4885NFKB2 3537/4885 |
| US-20220096667-A1 | Compound Targeting Norepinephrine Transporter | SLC6A2, SLC18A2, SLC6A3 | KMT2A 2778/4885NFKB1 3578/4885NFKB2 3618/4885 |
| US-20150368192-A1 | A METHOD OF SYNTHESIZING CREATINE DERIVATIVES | CKMT1A; CKMT1B, TNNI3, TNNT2 | KMT2A 3110/4885NFKB1 4483/4885NFKB2 4514/4885 |
| US-12285501-B2 | Compound targeting norepinephrine transporter | SLC6A2, SLC18A2, SLC6A3 | KMT2A 2778/4885NFKB1 3578/4885NFKB2 3618/4885 |
| US-20020061885-A1 | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists | ITGAL, ITGAV, ITGB3 | KMT2A 2591/4885NFKB1 2543/4885NFKB2 2068/4885 |
| US-20100234588-A1 | SYNTHETIC METHOD FOR CERATAMINE A AND B AND ANALOGS THEREOF | NR0B2, NR2C2, HRH3 | KMT2A 447/4885NFKB1 3263/4885NFKB2 3250/4885 |
| US-20060264608-A1 | Bi-directional synthesis of oligoguanidine transport agents | SLC29A2, SLC1A5, SLC29A1 | KMT2A 4248/4885NFKB1 1709/4885NFKB2 1903/4885 |
| US-20230272006-A1 | PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF | GMPS, PAM, SRM | KMT2A 3273/4885NFKB1 2460/4885NFKB2 3537/4885 |
| US-20060293328-A1 | Linear dicationic terphenyls and their aza analogues as antiparasitic agents | TPMT, TYMS, DDT | KMT2A 1167/4885NFKB1 2003/4885NFKB2 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.